ArticleOne health (Amsterdam, Netherlands)2018
zDALY: An adjusted indicator to estimate the burden of zoonotic diseases.
Article in One health (Amsterdam, Netherlands), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Socio-economic assessment of dog population management systems: a scoping review.Frontiers in veterinary science · 2025Pooled it
- Systematic review of bovine and zoonotic tuberculosis in the Western Pacific and the Southeast Asia regions of the World Health Organization.Frontiers in public health · 2024Pooled it
- The dual burden of animal and human zoonoses: A systematic review.PLoS neglected tropical diseases · 2022Pooled it
- The burden of zoonoses in Paraguay: A systematic review.PLoS neglected tropical diseases · 2021Pooled it
- Estimation of the global burden of tungiasis in endemic countries using a disability adjusted life-years modelling approach.BMC global and public health · 2026Article
- Prevalence and risk factors of neglected zoonoses in Ethiopian small ruminants: a focus on Q fever, brucellosis, chlamydiosis, and toxoplasmosis.One health outlook · 2026Article
- Spatial heterogeneity of Rift Valley fever burden in Kenya: a 10-year One Health zDALY evaluation.Science in One Health · 2026Article
- A framework for quantifying the multisectoral burden of animal disease to support decision making.Frontiers in veterinary science · 2025Review
- Editorial: Estimating non-monetary societal burden of livestock disease management.Frontiers in veterinary science · 2025Article
- Quantifying national burdens of foodborne disease-Four imperatives for global impact.PLOS global public health · 2025Review
- Echinococcus granulosus sensu lato control measures: a specific focus on vaccines for both definitive and intermediate hosts.Parasites & vectors · 2024Review
- Cystic echinococcosis in Cyprus: historical retrospective and finding of 2Parasitology · 2024Article
- A New Tool to Assess the Economic Impact of Q Fever on Dairy Cattle Farms.Animals : an open access journal from MDPI · 2024Article
- The global burden of neglected zoonotic diseases: Current state of evidence.One health (Amsterdam, Netherlands) · 2023Review
- Insights into the diagnosis, vaccines, and control of Taenia solium, a zoonotic, neglected parasite.Parasites & vectors · 2023Review
- 'One Health´ approach to end zoonotic TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023Review
- Development of core competencies for field veterinary epidemiology training programs.Frontiers in veterinary science · 2023Article
- Assessing the burden of Taenia solium cysticercosis in Burundi, 2020.BMC infectious diseases · 2022Article
- Alternative Paradigms in Animal Health Decisions: A Framework for Treating Animals Not Only as Commodities.Animals : an open access journal from MDPI · 2022Article
- The economic evaluation of Cystic echinococcosis control strategies focused on zoonotic hosts: A scoping review.PLoS neglected tropical diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The burden of human diseases in populations, or for an individual, is frequently estimated in terms of one of a number of Health Adjusted Life Years (HALYs). The Disability Adjusted Life Year (DALY) is a widely accepted HALY metric and is used by the World Health Organization and the Global Burden of Disease studies. Many human diseases are of animal origin and often cause ill health and production losses in domestic animals. The economic losses due to disease in animals are usually estimated in monetary terms. The monetary impact on animal health is not compatible with HALY approaches used to measure the impact on human health. To estimate the societal burden of zoonotic diseases that have substantial human and animal disease burden we propose methodology which can be accommodated within the DALY framework. Monetary losses due to the animal disease component of a zoonotic disease can be converted to an equivalent metric using a local gross national income per capita deflator. This essentially gives animal production losses a time trade-off for human life years. This is the time required to earn the income needed to replace that financial loss. This can then be assigned a DALY equivalent, termed animal loss equivalents (ALE), and added to the DALY associated with human ill health to give a modified DALY. This is referred to as the "zDALY". ALEs could also be estimated using willingness-to-pay for animal health or survey tools to estimate the replacement time value for animals with high societal or emotional value (for example pets) that cannot be calculated directly using monetary worth. Thus the zDALY estimates the impact of a zoonotic disease to animal and human health. The losses due to the animal disease component of the modified DALY are straightforward to calculate. A number of worked examples such as echinococcosis, brucellosis, Q fever and cysticercosis from a diverse spectrum of countries with different levels of economic development illustrate the use of the zDALY indicator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.